← Leaderboards
Carol J Wikstrand
Duke University
$4,716,145
Attributed
$4,716,145
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $608.1K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,716,145 · 4
By mechanism
P50$3,966,345 · 2
P30$749,800 · 1
P20$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Darell D Bigner$25,397,506
- Michael Rod Zalutsky$18,420,913
- Dorothy A Sipkins$8,543,606
- David Reardon$8,732,934
- Douglas Brock Cines$21,888,352
Others in their field
Top investigators on “Biomedical Facility”
- David Heimbrook · Leidos Biomedical Research, Inc.$269,207,281
- Mark S Klempner · Tufts Medical Center$133,377,807
- Joseph E Robertson · Oregon Health & Science University$129,896,064
- Lee Hamm · Tulane University Of Louisiana$114,986,978
- Peter Gordon Gillespie · Oregon Health And Science University$108,298,240
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$90,163,926
Research focus
Biomedical FacilityMonoclonal AntibodyDrug Screening /EvaluationNeoplasm /Cancer ChemotherapyAthymic MouseGliomaImmunocytochemistryHybridomasDisease /Disorder ModelNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radionuclide TherapyNeoplasm /CancerHistologyAntineoplasticsLaboratory RatMedulloblastomaHybrid AntibodyImmunoconjugatesAntitumor AntibodyCombination Cancer TherapyDosageNonhuman Therapy EvaluationCellsEngineering
Grant awards (23)
CORE--Basic, Preclinical, and Clinical Support Core$310,998
P50 · FY2008 · NS · contact PI
CORE--PRECLINICAL THERAPEUTIC REAGENT EVALUATION, PRODUCTION AND NEW DRUG PERMIT$273,884
P50 · FY2008 · CA · contact PI
CORE--Basic, Preclinical, and Clinical Support Core$320,321
P50 · FY2007 · NS · contact PI
CORE--PRECLINICAL THERAPEUTIC REAGENT EVALUATION, PRODUCTION AND NEW DRUG PERMIT$287,815
P50 · FY2007 · CA · contact PI
CORE--Basic, Preclinical, and Clinical Support Core$287,675
P50 · FY2006 · NS · contact PI
CORE 2 --REAGENT EVALUATION, PRODUCTION AND PERMIT$172,283
P50 · FY2006 · CA · contact PI
CORE--Basic, Preclinical, and Clinical Support Core$287,675
P50 · FY2005 · NS
CORE 2 --REAGENT EVALUATION, PRODUCTION AND PERMIT$172,290
P50 · FY2005 · CA
CORE--Basic, Preclinical, and Clinical Support Core$287,675
P50 · FY2004 · NS
CORE 2 --REAGENT EVALUATION, PRODUCTION AND PERMIT$172,462
P50 · FY2004 · CA
CORE--BASIC, PRECLINICAL, AND CLINICAL SUPPORT$313,976
P50 · FY2002 · NS
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$187,450
P30 · FY2002 · CA
CORE--THERAPEUTIC REAGENT EVALUATION, PRODUCTION AND NEW DRUG PERMIT CORE$0
P20 · FY2002 · CA
CORE--BASIC, PRECLINICAL, AND CLINICAL SUPPORT$313,976
P50 · FY2001 · NS
CORE--BASIC, PRECLINICAL, AND CLINICAL SUPPORT$288,255
P50 · FY2001 · NS
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$187,450
P30 · FY2001 · CA
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$187,450
P30 · FY2001 · CA
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$187,450
P30 · FY2001 · CA
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$0
P30 · FY2001 · CA
CORE--BASIC, PRECLINICAL, AND CLINICAL SUPPORT$288,255
P50 · FY2000 · NS
CORE--BASIC, PRECLINICAL, AND CLINICAL SUPPORT$188,805
P50 · FY2000 · NS
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$0
P30 · FY2000 · CA
CORE--HYBRIDOMA/IMMUNOHISTOCHEMISTRY$0
P30 · FY2000 · CA